Insulin degradation by adipose tissue. Studies at several levels of cellular organization
- PMID: 6445191
- PMCID: PMC1161537
- DOI: 10.1042/bj1860351
Insulin degradation by adipose tissue. Studies at several levels of cellular organization
Abstract
A systematic study of the degradation of physiological concentrations of 125I-labelled insulin was performed in intact fat-pads, isolated adipocytes and subcellular fractions of isolated adipocytes. The findings indicate that insulin is rapidly degraded to low-molecular-weight peptides and/or amino acids by the intact tissue and isolated cells. Of the total insulin-degradation products present after incubation with an intact fat-pad, 94% is recovered in the medium, indicating that these products are not retained by the cells or tissue. The plasma membranes do not degrade insulin significantly in the absence of reduced glutathione, and over 99% of the cellular degradative capacity is found in the postmicrosomal supernatant (cytosol). The cytosol degrades insulin to several labelled fragments that are intermediate in size between insulin and insulin A chain, as well as to the low-molecular-weight tissue degradation products. Inclusion of plasma membranes with cytosol accelerates the cleavage of the intermediate fragments to the size of the small products seen with the intact tissue. However, plasma membranes do not increase the initial step in the degradation of insulin when incubated with cytosol, suggesting that the insulin receptor is not involved with the direct cleavage of insulin. This study supports the hypothesis that the bulk of insulin degradation occurs in the adipocyte cytosol, where intermediate-sized fragments are generated and rapidly cleaved to smaller products by the plasma membrane and quickly released into the surrounding medium.
Similar articles
-
Receptor-mediated degradation by rat adipocytes: comparison of A-14 with A-19 125I-labelled insulin.Endocrinol Jpn. 1984 Jun;31(3):321-6. doi: 10.1507/endocrj1954.31.321. Endocrinol Jpn. 1984. PMID: 6389102
-
Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies.Mol Cell Endocrinol. 1990 Sep 10;72(3):175-85. doi: 10.1016/0303-7207(90)90142-u. Mol Cell Endocrinol. 1990. PMID: 2289630
-
Insulin degradation by isolated fat cells and their subcellular fractions.Diabetes. 1975 Nov;24(11):1011-9. doi: 10.2337/diab.24.11.1011. Diabetes. 1975. PMID: 241673
-
Pathways of insulin degradation in isolated adipocytes: evaluation by gel filtration and differential precipitation.Metabolism. 1985 Apr;34(4):354-63. doi: 10.1016/0026-0495(85)90225-2. Metabolism. 1985. PMID: 3884964
-
Hepatic metabolism of insulin.Am J Med. 1988 Nov 28;85(5A):71-6. doi: 10.1016/0002-9343(88)90399-3. Am J Med. 1988. PMID: 3057896 Review.
Cited by
-
The fate of insulin in cardiac muscle. Studies on isolated muscle cells from adult rat heart.Biochem J. 1982 Sep 15;206(3):655-62. doi: 10.1042/bj2060655. Biochem J. 1982. PMID: 6756394 Free PMC article.
-
Conversion of biosynthetic human proinsulin to partially cleaved intermediates by collagenase proteinases adsorbed to isolated rat adipocytes.Biochem J. 1988 Oct 1;255(1):277-84. Biochem J. 1988. PMID: 2848505 Free PMC article.
-
Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.Proc Natl Acad Sci U S A. 1986 Jun;83(12):4147-51. doi: 10.1073/pnas.83.12.4147. Proc Natl Acad Sci U S A. 1986. PMID: 2424018 Free PMC article.
-
The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design.Biomolecules. 2023 Oct 7;13(10):1492. doi: 10.3390/biom13101492. Biomolecules. 2023. PMID: 37892174 Free PMC article. Review.
-
Mechanisms of insulin degradation by isolated rat adipocytes.Mol Cell Biochem. 1982 Aug 20;47(1):23-9. doi: 10.1007/BF00241562. Mol Cell Biochem. 1982. PMID: 6752691 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical